Biotransformation of sulindac in end-stage renal disease.

MLA

Gibson, T. P., et al. “Biotransformation of Sulindac in End-Stage Renal Disease.” Clinical Pharmacology and Therapeutics, vol. 42, no. 1, July 1987, pp. 82–88. EBSCOhost, https://doi.org/10.1038/clpt.1987.112.

APA

Gibson, T. P., Dobrinska, M. R., Lin, J. H., Entwistle, L. A., & Davies, R. O. (1987). Biotransformation of sulindac in end-stage renal disease. Clinical Pharmacology and Therapeutics, 42(1), 82–88. https://doi.org/10.1038/clpt.1987.112

Chicago

Gibson, T P, M R Dobrinska, J H Lin, L A Entwistle, and R O Davies. 1987. “Biotransformation of Sulindac in End-Stage Renal Disease.” Clinical Pharmacology and Therapeutics 42 (1): 82–88. doi:10.1038/clpt.1987.112.